﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Society of Diabetic Nephropathy Prevention</PublisherName>
      <JournalTitle>Journal of Nephropathology</JournalTitle>
      <Issn>2251-8363</Issn>
      <Volume>6</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2017</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>Tempol effect on epithelial-mesenchymal transition induced by hyperglycemia</ArticleTitle>
    <FirstPage>1</FirstPage>
    <LastPage>4</LastPage>
    <ELocationID EIdType="doi">10.15171/jnp.2017.01</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Jafari</LastName>
      </Author>
      <Author>
        <FirstName>Farahnaz</FirstName>
        <LastName>Dadras</LastName>
      </Author>
      <Author>
        <FirstName>Hamid Reza</FirstName>
        <LastName>Ghadimipour</LastName>
      </Author>
      <Author>
        <FirstName>Mohamad Ali</FirstName>
        <LastName>Seif Rabiei</LastName>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Khoshjou</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.15171/jnp.2017.01</ArticleId>
    </ArticleIdList>
    <History>
    </History>
    <Abstract>Background: One of common mechanisms in pathophysiology of chronic kidney diseases is epithelial-mesenchymal transition (EMT). On the other hand oxidative stress has been known to participate in kidney damage of diabetic nephropathy (DN). Objectives: We studied if tempol, a well-known antioxidant agent, can ameliorate EMT in DN induced in male rats. Materials and Methods: Twenty-seven male rats were equally divided in to 4 groups. Group I (control or C), group II (diabetic or D), group III (T) rats which was given tempol (100 mg/kg/day) by gavages for 28 days and group IV (D&amp;T) was diabetic rats that also received same dose of tempol. After treatment, their kidneys were studied by immunohistochemicalstaining. Results: Pathological changes in the kidney were detected concurrently with increasing kidney weight and urinary albumin excretion. In addition, EMT indices, i.e. decline of E-cadherin and increase of α SMA staining were significantly emerged in the renal tubular cells of diabetic group and were partially modified in diabetic group which were simultaneously treated by tempol. Conclusions: Tempol can modify, but not significantly, EMT induced by DN.</Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Tempol</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Epithelial mesenchymal transition</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Diabetic nephropathy</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>